Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Politics & Policy

Innovative Medicines Initiative selects proposals

May 21, 2009 12:15 AM UTC

Europe's Innovative Medicines Initiative (IMI) selected 15 proposals to receive EUR 246 million ($332 million) under a five-year, EUR 2 billion program to relieve bottlenecks in drug discovery and development. The projects will receive EUR 110 million from the EC with an in-kind contribution of EUR 136 million from participating European Federation of Pharmaceutical Industries and Associations (EFPIA) members.

The 15 projects involve improving safety prediction and pharmacovigilance; improving prediction of efficacy in diabetes and brain and respiratory disorders; and education and training in support of medicines development. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article